Shamburg News · 8-K filed Oct 1, 2026, 8:15 AM EDT
SpyGlass Pharma Completes $13 Million Acquisition of Advanced Vision Science, Inc.
SGP · SpyGlass Pharma, Inc.
- Acquisition
- Material agreement
- Reg FD disclosure
- Materiality: high
On October 1, 2026, SpyGlass Pharma, Inc. entered into a Stock Purchase Agreement with Santen Holdings US, Inc. and Santen Pharmaceutical Co., Ltd. and closed the acquisition of 100% of the outstanding shares of Advanced Vision Science, Inc. (AVS), its intraocular lens supplier. The purchase price was $13,000,000, subject to customary adjustments and a post-Closing adjustment. In connection with the Closing, AVS and Santen entered into an Amended and Restated Supply and Distribution Agreement and cross license agreements.
Source: SEC EDGAR, Form 8-K, Items 7.01, 8.01, 9.01, accession 0001778922-26-000049.
Written from the filing by Shamburg Markets. Figures are as reported by the company.